ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS

Michael Dorsch,Sean Pokorney,Mary Birmingham,John A. House,Kenneth Todd Moore,Bobbie James,Sue Mashni,Kevin Thomas,Kevin Anstrom,Gerald Naccarelli,Peter Berger,Gregory Fermann,Christopher B. Granger,Elaine Hylek

ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS

2019

Michael Dorsch
Sean Pokorney
Mary Birmingham
John A. House
Kenneth Todd Moore
Bobbie James
Sue Mashni
Kevin Thomas
Kevin Anstrom
Gerald Naccarelli
Peter Berger
Gregory Fermann
Christopher B. Granger
Elaine Hylek

Renal function has been associated with outcomes of patients anticoagulated for atrial fibrillation (AF). We hypothesize that oral anticoagulant (OAC) prescribing patterns and clinical outcomes change based on chronic kidney disease (CKD) status. Included patients from the Premier Health Database

Keywords:

Renal function
Atrial fibrillation
Kidney disease
Anticoagulant
Diabetes mellitus
Cardiology
Internal medicine
Medicine
Aspirin
oral anticoagulation
oral anticoagulant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations